Market revenue in 2023 | USD 491.4 million |
Market revenue in 2030 | USD 644.6 million |
Growth rate | 4% (CAGR from 2023 to 2030) |
Largest segment | Cmos & cdmos |
Fastest growing segment | CMOs & CDMOS |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopharmaceutical Companies, CMOs & CDMOS, Academic And Research Organizations |
Key market players worldwide | Danone SA, Roche Holding AG ADR, Koninklijke DSM NV, Lonza Group Ltd, Novonesis AS ADR, Biocon, BioVectra, TerraVia - Assets, BiOZEEN |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial fermentation technology market will help companies and investors design strategic landscapes.
Cmos & cdmos was the largest segment with a revenue share of 41.92% in 2023. Horizon Databook has segmented the Spain microbial fermentation technology market based on biopharmaceutical companies, cmos & cdmos, academic and research organizations covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is one of the key economies in Europe for the biotechnology and pharmaceutical industry. Minimum intervention pertaining to government regulations and laws to attract R&D teams & manufacturers is a major factor driving the country’s market. Relaxed regulations in the manufacturing and trading sector can also encourage companies to establish their production facilities in Spain, thus resulting in the expansion of microbial fermentation technology market.
The country is also anticipated to exhibit immense growth potential during the forecast period due to the increasing interest of investors in innovative biological therapies. There are over 3,000 biotechnology companies in the country, of which, around 50% of companies lead the healthcare industry with the launch of novel products in diagnostics and therapeutics.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain microbial fermentation technology market , including forecasts for subscribers. This country databook contains high-level insights into Spain microbial fermentation technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account